Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity

Latha Ramalingam, Eunjin Oh, Stephanie M. Yoder, Joseph T. Brozinick, Michael A. Kalwat, Alexander J. Groffen, Matthijs Verhage, Debbie C. Thurmond

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Exocytosis of intracellular vesicles, such as insulin granules, is carried out by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) and Sec1/Munc18 (SM) proteins. An additional regulatory protein, Doc2b (double C2 domain), has recently been implicated in exocytosis from clonal β-cells and 3T3-L1 adipocytes. Here, we investigated the role of Doc2b in insulin secretion, insulin sensitivity, and the maintenance of whole-body glucose homeostasis. Doc2b heterozygous (Doc2b+/-) and homozygous (Doc2b-/-) knockout mice exhibited significant whole-body glucose intolerance and peripheral insulin resistance, compared with wild-type littermates. Correspondingly, Doc2b+/-and Doc2b-/- mice exhibited decreased responsiveness of pancreatic islets to glucose in vivo, with significant attenuation of both phases of insulin secretion ex vivo. Peripheral insulin resistance correlated with ablated insulin-stimulated glucose uptake and GLUT4 vesicle translocation in skeletal muscle from Doc2b-deficient mice, which was coupled to impairments in Munc18c-syntaxin 4 dissociation and in SNARE complex assembly. Hence, Doc2b is a key positive regulator of Munc18c-syntaxin 4-mediated insulin secretion as well as of insulin responsiveness in skeletal muscle, and thus a key effector for glucose homeostasis in vivo. Doc2b's actions in glucose homeostasis may be related to its ability to bind Munc18c and/or directly promote fusion of insulin granules and GLUT4 vesicles in a stimulus-dependent manner.

Original languageEnglish (US)
Pages (from-to)2424-2432
Number of pages9
JournalDiabetes
Volume61
Issue number10
DOIs
StatePublished - Oct 1 2012
Externally publishedYes

Fingerprint

Insulin Resistance
Skeletal Muscle
Insulin
Glucose
Qa-SNARE Proteins
Homeostasis
Exocytosis
Vascular Resistance
Munc18 Proteins
3T3-L1 Cells
SNARE Proteins
Glucose Intolerance
Islets of Langerhans
Adipocytes
Knockout Mice
Proteins
Maintenance

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Ramalingam, L., Oh, E., Yoder, S. M., Brozinick, J. T., Kalwat, M. A., Groffen, A. J., ... Thurmond, D. C. (2012). Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity. Diabetes, 61(10), 2424-2432. https://doi.org/10.2337/db11-1525

Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity. / Ramalingam, Latha; Oh, Eunjin; Yoder, Stephanie M.; Brozinick, Joseph T.; Kalwat, Michael A.; Groffen, Alexander J.; Verhage, Matthijs; Thurmond, Debbie C.

In: Diabetes, Vol. 61, No. 10, 01.10.2012, p. 2424-2432.

Research output: Contribution to journalArticle

Ramalingam, L, Oh, E, Yoder, SM, Brozinick, JT, Kalwat, MA, Groffen, AJ, Verhage, M & Thurmond, DC 2012, 'Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity', Diabetes, vol. 61, no. 10, pp. 2424-2432. https://doi.org/10.2337/db11-1525
Ramalingam L, Oh E, Yoder SM, Brozinick JT, Kalwat MA, Groffen AJ et al. Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity. Diabetes. 2012 Oct 1;61(10):2424-2432. https://doi.org/10.2337/db11-1525
Ramalingam, Latha ; Oh, Eunjin ; Yoder, Stephanie M. ; Brozinick, Joseph T. ; Kalwat, Michael A. ; Groffen, Alexander J. ; Verhage, Matthijs ; Thurmond, Debbie C. / Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity. In: Diabetes. 2012 ; Vol. 61, No. 10. pp. 2424-2432.
@article{ac7a4c125e8948858cdce5f44c98a686,
title = "Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity",
abstract = "Exocytosis of intracellular vesicles, such as insulin granules, is carried out by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) and Sec1/Munc18 (SM) proteins. An additional regulatory protein, Doc2b (double C2 domain), has recently been implicated in exocytosis from clonal β-cells and 3T3-L1 adipocytes. Here, we investigated the role of Doc2b in insulin secretion, insulin sensitivity, and the maintenance of whole-body glucose homeostasis. Doc2b heterozygous (Doc2b+/-) and homozygous (Doc2b-/-) knockout mice exhibited significant whole-body glucose intolerance and peripheral insulin resistance, compared with wild-type littermates. Correspondingly, Doc2b+/-and Doc2b-/- mice exhibited decreased responsiveness of pancreatic islets to glucose in vivo, with significant attenuation of both phases of insulin secretion ex vivo. Peripheral insulin resistance correlated with ablated insulin-stimulated glucose uptake and GLUT4 vesicle translocation in skeletal muscle from Doc2b-deficient mice, which was coupled to impairments in Munc18c-syntaxin 4 dissociation and in SNARE complex assembly. Hence, Doc2b is a key positive regulator of Munc18c-syntaxin 4-mediated insulin secretion as well as of insulin responsiveness in skeletal muscle, and thus a key effector for glucose homeostasis in vivo. Doc2b's actions in glucose homeostasis may be related to its ability to bind Munc18c and/or directly promote fusion of insulin granules and GLUT4 vesicles in a stimulus-dependent manner.",
author = "Latha Ramalingam and Eunjin Oh and Yoder, {Stephanie M.} and Brozinick, {Joseph T.} and Kalwat, {Michael A.} and Groffen, {Alexander J.} and Matthijs Verhage and Thurmond, {Debbie C.}",
year = "2012",
month = "10",
day = "1",
doi = "10.2337/db11-1525",
language = "English (US)",
volume = "61",
pages = "2424--2432",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "10",

}

TY - JOUR

T1 - Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity

AU - Ramalingam, Latha

AU - Oh, Eunjin

AU - Yoder, Stephanie M.

AU - Brozinick, Joseph T.

AU - Kalwat, Michael A.

AU - Groffen, Alexander J.

AU - Verhage, Matthijs

AU - Thurmond, Debbie C.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Exocytosis of intracellular vesicles, such as insulin granules, is carried out by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) and Sec1/Munc18 (SM) proteins. An additional regulatory protein, Doc2b (double C2 domain), has recently been implicated in exocytosis from clonal β-cells and 3T3-L1 adipocytes. Here, we investigated the role of Doc2b in insulin secretion, insulin sensitivity, and the maintenance of whole-body glucose homeostasis. Doc2b heterozygous (Doc2b+/-) and homozygous (Doc2b-/-) knockout mice exhibited significant whole-body glucose intolerance and peripheral insulin resistance, compared with wild-type littermates. Correspondingly, Doc2b+/-and Doc2b-/- mice exhibited decreased responsiveness of pancreatic islets to glucose in vivo, with significant attenuation of both phases of insulin secretion ex vivo. Peripheral insulin resistance correlated with ablated insulin-stimulated glucose uptake and GLUT4 vesicle translocation in skeletal muscle from Doc2b-deficient mice, which was coupled to impairments in Munc18c-syntaxin 4 dissociation and in SNARE complex assembly. Hence, Doc2b is a key positive regulator of Munc18c-syntaxin 4-mediated insulin secretion as well as of insulin responsiveness in skeletal muscle, and thus a key effector for glucose homeostasis in vivo. Doc2b's actions in glucose homeostasis may be related to its ability to bind Munc18c and/or directly promote fusion of insulin granules and GLUT4 vesicles in a stimulus-dependent manner.

AB - Exocytosis of intracellular vesicles, such as insulin granules, is carried out by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) and Sec1/Munc18 (SM) proteins. An additional regulatory protein, Doc2b (double C2 domain), has recently been implicated in exocytosis from clonal β-cells and 3T3-L1 adipocytes. Here, we investigated the role of Doc2b in insulin secretion, insulin sensitivity, and the maintenance of whole-body glucose homeostasis. Doc2b heterozygous (Doc2b+/-) and homozygous (Doc2b-/-) knockout mice exhibited significant whole-body glucose intolerance and peripheral insulin resistance, compared with wild-type littermates. Correspondingly, Doc2b+/-and Doc2b-/- mice exhibited decreased responsiveness of pancreatic islets to glucose in vivo, with significant attenuation of both phases of insulin secretion ex vivo. Peripheral insulin resistance correlated with ablated insulin-stimulated glucose uptake and GLUT4 vesicle translocation in skeletal muscle from Doc2b-deficient mice, which was coupled to impairments in Munc18c-syntaxin 4 dissociation and in SNARE complex assembly. Hence, Doc2b is a key positive regulator of Munc18c-syntaxin 4-mediated insulin secretion as well as of insulin responsiveness in skeletal muscle, and thus a key effector for glucose homeostasis in vivo. Doc2b's actions in glucose homeostasis may be related to its ability to bind Munc18c and/or directly promote fusion of insulin granules and GLUT4 vesicles in a stimulus-dependent manner.

UR - http://www.scopus.com/inward/record.url?scp=84866596184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866596184&partnerID=8YFLogxK

U2 - 10.2337/db11-1525

DO - 10.2337/db11-1525

M3 - Article

C2 - 22698913

AN - SCOPUS:84866596184

VL - 61

SP - 2424

EP - 2432

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 10

ER -